Bacterial vaginosis is the most common cause of abnormal vaginal discharge in women of reproductive age, yet it remains widely misunderstood — often confused with thrush by patients presenting at the pharmacy counter. With the renewed Women's Health Strategy placing greater emphasis on accessible healthcare for women, community pharmacists are well placed to help patients distinguish between the two conditions and access appropriate treatment.

What is bacterial vaginosis?

Bacterial vaginosis (BV) occurs when the normal balance of bacteria in the vagina is disrupted, with an overgrowth of anaerobic organisms — most commonly Gardnerella vaginalis — replacing the protective Lactobacillus species. According to the British Association for Sexual Health and HIV (BASHH), BV affects approximately one in three women at some point, though many cases are asymptomatic.

The hallmark symptom is a thin, greyish-white discharge with a characteristic fishy odour, which often worsens after unprotected intercourse or during menstruation. Unlike thrush, BV rarely causes significant itching or soreness — a key distinguishing feature that pharmacists can use during consultations.

The thrush distinction: why it matters

Patients frequently self-diagnose thrush when they actually have BV. A 2023 study published in BMJ Open found that up to 60% of women who self-treated for thrush with over-the-counter antifungals did not actually have candidiasis. Misidentification delays effective treatment and can lead to unnecessary antifungal use.

Community pharmacists who identify BV-consistent symptoms should refer patients to their GP or sexual health clinic for diagnosis and prescription treatment, as BV cannot be treated with over-the-counter products alone in the UK.

Treatment options

First-line treatment for BV in the UK, per NICE Clinical Knowledge Summary guidance, is oral metronidazole 400mg twice daily for five to seven days. Alternatives include intravaginal metronidazole gel (0.75%) for five nights or intravaginal clindamycin cream (2%) for seven nights.

All of these are prescription-only medicines, so the pharmacist's role centres on:

• Accurate triage — recognising BV symptoms and referring appropriately
• Dispensing support — advising on alcohol avoidance with metronidazole, explaining the importance of completing the course, and flagging potential interactions
• Recurrence counselling — BV recurs in up to 50% of women within 12 months, according to BASHH guidelines

Self-care advice pharmacists can offer

While treatment requires a prescription, pharmacists can recommend evidence-based self-care measures:

• Avoid perfumed soaps, shower gels and bubble baths in the vulval area
• Do not douche — vaginal douching disrupts the protective Lactobacillus flora
• Use water or an emollient wash for intimate hygiene
• Wear cotton underwear and avoid tight-fitting clothing

Some patients ask about over-the-counter lactic acid gels (such as Balance Activ or Relactagel). These are classified as medical devices, not medicines, and evidence for their effectiveness is limited. A Cochrane review found insufficient evidence to recommend them as a standalone treatment, though some clinicians suggest they may help maintain vaginal pH between episodes. Pharmacists should explain this uncertainty honestly.

When to refer

Immediate GP or sexual health clinic referral is appropriate when:

• Symptoms are present for the first time (to confirm diagnosis)
• The patient is pregnant — BV in pregnancy is associated with an increased risk of preterm birth and late miscarriage, and treatment decisions require clinical assessment
• Symptoms recur within three months of treatment
• The patient has concurrent symptoms suggesting a sexually transmitted infection (pelvic pain, intermenstrual bleeding, dysuria)
• The patient is under 16

The Women's Health Strategy context

The Department of Health and Social Care's renewed Women's Health Strategy, announced in April 2026, emphasises that women's voices should be at the heart of healthcare planning. For conditions like BV — where stigma, embarrassment and self-misdiagnosis are common barriers to appropriate treatment — pharmacy represents an accessible first point of contact.

According to PharmSee's tracker of 1,742 active pharmacy vacancies across England, community pharmacy remains the most accessible healthcare setting for many women, with over 13,000 pharmacies operating nationally. Pharmacists who can confidently distinguish BV from thrush and counsel on self-care are providing exactly the kind of accessible women's healthcare the strategy envisions.

Sources

• BASHH UK national guideline for the management of bacterial vaginosis (2023 update)
• NICE Clinical Knowledge Summary: Bacterial vaginosis
• Department of Health and Social Care, Women's Health Strategy renewal (April 2026)
• PharmSee pharmacy and vacancy data, accessed April 2026

For pharmacy job listings and salary data, visit PharmSee Jobs. To explore pharmacy density in your area, try the pharmacy search tool.